Analysis and Countermeasures on Inspected Defects in Newly Revised Drug GMP Certification in Tibetan Medicine Enterprises of Qinghai Province

Han Dabin, Liu Xueliang, Pan Ping, Chen Peng, Yu Yaqiong, Liu Haiqing

Chinese Pharmaceutical Affairs ›› 2017, Vol. 31 ›› Issue (1) : 32-36.

Chinese Pharmaceutical Affairs ›› 2017, Vol. 31 ›› Issue (1) : 32-36. DOI: 10.16153/j.1002-7777.2017.01.007
Quality Management

Analysis and Countermeasures on Inspected Defects in Newly Revised Drug GMP Certification in Tibetan Medicine Enterprises of Qinghai Province

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2017, 31(1): 32-36 https://doi.org/10.16153/j.1002-7777.2017.01.007

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections
Recommended

/